Matches in Wikidata for { <http://www.wikidata.org/entity/Q62809466> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q62809466 description "clinical trial" @default.
- Q62809466 description "ensayu clínicu" @default.
- Q62809466 description "klinisch onderzoek" @default.
- Q62809466 description "клінічне випробування" @default.
- Q62809466 description "կլինիկական փորձարկում" @default.
- Q62809466 description "临床试验" @default.
- Q62809466 name "Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b" @default.
- Q62809466 type Item @default.
- Q62809466 label "Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b" @default.
- Q62809466 prefLabel "Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b" @default.
- Q62809466 P1050 Q62809466-0CEB49E3-E96C-4BAF-B211-0DDBB6923E44 @default.
- Q62809466 P1050 Q62809466-2BA9A175-E575-458D-8E98-26D335AE0B01 @default.
- Q62809466 P1050 Q62809466-D5852DEF-8234-4577-AF32-B4B6F4F0BEBC @default.
- Q62809466 P1132 Q62809466-149A145E-CE6C-4EE2-8426-E44664B73127 @default.
- Q62809466 P1476 Q62809466-060F6B86-DE9B-49DC-BCB2-93A6756CDD56 @default.
- Q62809466 P2899 Q62809466-DA4C4D8E-4517-4949-9A1D-036340E74799 @default.
- Q62809466 P3098 Q62809466-3754B9FD-E1C1-4C2C-BA19-6513A9D12AE3 @default.
- Q62809466 P31 Q62809466-053132E0-A5E9-4B9E-A210-5AD0102B6CEB @default.
- Q62809466 P4135 Q62809466-CE53C08E-9D5C-4492-B4C9-091321DA2F43 @default.
- Q62809466 P4844 Q62809466-B459E70E-D040-4F9F-A153-BDD3EBE9E71A @default.
- Q62809466 P580 Q62809466-B6223034-AC44-4E88-A00D-7DF903A2B582 @default.
- Q62809466 P582 Q62809466-5DAE0825-0312-4646-8AE4-79914D2ECB9A @default.
- Q62809466 P6099 Q62809466-332DAAF2-E86C-4096-984A-D945B9D081BB @default.
- Q62809466 P8005 Q62809466-B57247B7-EA26-4C77-A58D-A273FA791D40 @default.
- Q62809466 P8363 Q62809466-864396E1-90CA-42D2-8FA4-D07563DE3355 @default.
- Q62809466 P859 Q62809466-3F77389E-26F9-42EF-B875-BC92C6314CD7 @default.
- Q62809466 P1050 Q131742 @default.
- Q62809466 P1050 Q154869 @default.
- Q62809466 P1050 Q157661 @default.
- Q62809466 P1132 "+105" @default.
- Q62809466 P1476 "Multicenter, Open-label, Phase II Safety and Efficacy Study of All-oral Combination Narlaprevir/Ritonavir and Daclatasvir Administered for 12 Weeks in Patients With Genotype 1b Chronic Hepatitis C" @default.
- Q62809466 P2899 "+18" @default.
- Q62809466 P3098 "NCT03485846" @default.
- Q62809466 P31 Q30612 @default.
- Q62809466 P4135 "+70" @default.
- Q62809466 P4844 Q422618 @default.
- Q62809466 P580 "2017-11-27T00:00:00Z" @default.
- Q62809466 P582 "2018-08-29T00:00:00Z" @default.
- Q62809466 P6099 Q42824440 @default.
- Q62809466 P8005 Q76651189 @default.
- Q62809466 P8363 Q78089383 @default.
- Q62809466 P859 Q18398598 @default.